A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit ...

Bufadienolides, a class of cardiotonic steroids primarily isolated from toad venom, have emerged as potent agents in the field of cancer therapeutics. Their bioactivity is largely attributed to their ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most ...

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Researchers at RMIT University in Melbourne have developed minuscule 'nanodots' that show promise for future targeted cancer therapies. These metal particles, derived from molybdenum oxide, are ...

Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...

Researchers have created tiny metal-based particles that push cancer cells over the edge while leaving healthy cells mostly unharmed. The particles work by increasing internal stress in cancer cells ...

A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...